TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD Inactive Instrument
Tikun Olam-Cannbit Pharmaceuticals Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
TKUN
IL0010843675
Pharmaceuticals
| Sales 2022 | 49.3 185.07 3.92K | Sales 2023 | 44.23 166.04 3.52K | Capitalization | 25.49M 95.69M 2.03B |
|---|---|---|---|---|---|
| Net income 2022 | -48M -180M -3.82B | Net income 2023 | -88M -330M -7.01B | EV / Sales 2022 | 1,234,605 x |
| Net Debt 2022 | 17.5M 65.7M 1.39B | Net Debt 2023 | 13.42M 50.37M 1.07B | EV / Sales 2023 | 879,698 x |
| P/E ratio 2022 |
-0.97
x | P/E ratio 2023 |
-0.22
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.73% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 14/02/15 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Tikun Olam Cannbit Pharmaceuticals Ltd, formerly Cannbit Pharmaceuticals Ltd, is an Israel-based company that produces medical cannabis. The Company engages in growing and cultivating medical cannabis products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +22.87% | 3.66B | |
| +111.68% | 2B | |
| +90.48% | 61.69M |
